This new weight loss medication is a GLP-1 receptor agonist that mimics GLP-1, an incretin hormone that our body makes when it senses there is food in the intestine. These hormones are released by the small intestine within minutes after eating and aid in the function of digestion and appetite suppression.
Incretins trigger the pancreas to release the right amount of insulin when glucose levels are high, helping move sugar from the blood into other body tissues where it is used for energy. It blocks other sources of sugar. It was also found that the hormone aids in the function of digestion by decreasing the speed at which food leaves your stomach, leaving you feeling full longer.
Semaglutide weight loss plus lifestyle interventions were associated with a sustained reduction in body weight.
Your collection is already set up for you with fields and content. Add your own, or import content from a CSV file. Add fields for any type of content you want to display, such as rich text, images, videos and more. You can also collect and store information from your site visitors using input elements like custom forms and fields.